Pennsaid Side Effects
Generic name: diclofenac topical
Note: This document contains side effect information about diclofenac topical. Some of the dosage forms listed on this page may not apply to the brand name Pennsaid.
Some side effects of Pennsaid may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to diclofenac topical: topical film extended release
Other dosage forms:
Get emergency medical help if you have any of these signs of an allergic reaction while taking diclofenac topical (the active ingredient contained in Pennsaid) hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Although the risk of serious side effects is low when diclofenac is applied to the skin, you should be aware of side effects that can occur if the medication is absorbed into your bloodstream.
Stop using this medicine and call your doctor at once if you have a serious side effect such as:
-
chest pain, slurred speech, problems with vision or balance, and feeling weak or short of breath;
-
bloody or tarry stools, coughing up blood or vomit that looks like coffee grounds;
-
fever, chills, body aches, flu symptoms;
-
pale or yellowed skin, dark colored urine, confusion;
-
swelling or rapid weight gain;
-
urinating less than usual or not at all;
-
nausea, upper stomach pain, itching, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
-
skin rash, bruising, severe tingling, numbness, pain, muscle weakness;
-
fever, sore throat, and headache with a severe blistering, peeling, and red skin rash; or
-
the first sign of any skin rash, no matter how mild.
Less serious side effects of diclofenac topical may include:
-
mild nausea, vomiting;
-
diarrhea, constipation;
-
upset stomach, heartburn, gas;
-
dizziness; or
-
mild itching, burning, redness, or other skin irritation where the patch was worn.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
For Healthcare Professionals
Applies to diclofenac topical: topical film extended release, topical gel, topical solution
Local
Local application site reactions have been reported in 75% to 86% of patients and have included rash (35% to 36%), pruritus (31% to 52%), dry skin (25% to 27%), contact dermatitis (19% to 33%), pain (15% to 26%), paresthesia (8% to 20%), exfoliation (6% to 24%), vesiculobullous rash (4%), edema (3% to 4%), hyperesthesia (3%), photosensitivity reaction (3%), acne (1%), alopecia (1% to 2%), erythema (less than 1%), irritation (less than 1%), and papules (less than 1%).
The gel vehicle has also been associated with a high incidence of application site reactions (71% to 86%), including pruritus (45% to 59%), pain (22% to 30%), rash (17% to 20%), dry skin (12% to 17%), exfoliation (4% to 13%), and paresthesia (4% to 20%). Other local reactions have included skin carcinoma, hypertonia, lacrimation disorder, maculopapular rash, purpuric rash, skin hypertrophy, and vasodilation in less than 1% of patients.
Dermatologic
Dermatologic side effects have included pruritus (4%), rash (2% to 4%), dry skin (3%), contact dermatitis (2%), pain (1% to 2%), skin carcinoma (2%), and skin ulcer (1% to 2%). Other dermatologic side effects have included skin hypertrophy, paresthesia, seborrhea, urticaria in less than 1% of patients, and skin discoloration. The gel vehicle has been associated with acne (1% to 2%), herpes simplex (2%), maculopapular rash (2%), and skin nodule (2%).
Cardiovascular
Cardiovascular side effects have included hypertension (1% to 2%), migraine (1%), and palpitation. The gel vehicle has been associated with phlebitis (2%).
Endocrine
Endocrine side effects have included hyperglycemia (greater than 1%).
Gastrointestinal
Gastrointestinal side effects have included dyspepsia (2% to 3%), diarrhea (2%), abdominal pain (1% to 2%), dry mouth, gastroenteritis, mouth ulceration, nausea, rectal hemorrhage, and ulcerative stomatitis. The gel vehicle has been associated with constipation (2%).
Genitourinary
Genitourinary side effects have included hematuria (2%).
Hepatic
Hepatic side effects have included elevations in serum transaminases in up to 15% of patients as well as rare cases of hepatitis, jaundice, and fatal fulminant hepatitis. Liver injury is most likely to occur in older females in the first 6 months of use.
Immunologic
Immunologic side effects have included infection and flu syndrome (greater than 1%).
Metabolic
Metabolic side effects have included increased creatine phosphokinase (4%), increased SGOT (3%), increased SGPT (2%), increased creatinine (2%), hypercholesterolemia (1%), hyperglycemia (1%), and creatinine increased. The gel vehicle has been associated with edema (2%).
Musculoskeletal
Musculoskeletal side effects have included myalgia (2 to 3%), arthralgia (2%), arthrosis (2%), and leg cramps.
Nervous system
Nervous system side effects have included headache (7%), hypokinesia (2%), depression, dizziness, drowsiness, lethargy, paresthesia, and paresthesia at application site. The gel vehicle has been associated with dizziness (4%) and anxiety (1% to 2%).
Ocular
Ocular side effects have included conjunctivitis (2 to 4%) eye pain (2%), blurred or abnormal vision, cataract, and eye disorder.
Respiratory
Respiratory side effects have included asthma, dyspnea, pharyngitis, pneumonia, rhinitis, and sinusitis in 2% of patients.
Renal
Renal side effects have included increased creatinine (2%).
Other
Other side effects have included flu syndrome (1 to 10%), accidental injury (4%), infection (4%), back pain (2 to 4%), asthenia (2%), neck pain (2%), pain (2%), chest pain (1 to 2%), ear pain, and taste perversion.
More Pennsaid resources
- Pennsaid Prescribing Information (FDA)
- Pennsaid Consumer Overview
- Pennsaid Topical Advanced Consumer (Micromedex) - Includes Dosage Information
- Pennsaid solution MedFacts Consumer Leaflet (Wolters Kluwer)
- Solaraze Prescribing Information (FDA)
- Solaraze topical Monograph (AHFS DI)
- Solaraze gel MedFacts Consumer Leaflet (Wolters Kluwer)
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.


